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forefoot and blood stream co-infection in a
haemodialysis patient: a case report
Christine Valentiny1, Harald Dirschmid2 and Karl Lhotta1*Abstract
Background: Streptococcus uberis, the most frequent cause of mastitis in lactating cows, is considered non-pathogenic
for humans. Only a few case reports have described human infections with this microorganism, which is notoriously
difficult to identify.
Case presentation: We report the case of a 75-year-old male haemodialysis patient, who developed a severe foot
infection with osteomyelitis and bacteraemia. Both Streptococcus uberis and Staphylococcus aureus were identified
in wound secretion and blood samples using mass spectrometry. The presence of Streptococcus uberis was confirmed by
superoxide dismutase A sequencing. The patient recovered after amputation of the forefoot and antibiotic treatment
with ampicillin/sulbactam. He had probably acquired the infection while walking barefoot on cattle pasture land.
Conclusion: This is the first case report of a human infection with Streptococcus uberis with identification of the
microorganism using modern molecular technology. We propose that Staphylococcus aureus co-infection was a
prerequisite for deep wound and bloodstream infection with Streptococcus uberis.
Keywords: Haemodialysis, Infection, StreptococcusBackground
End-stage renal disease is a state of severe immunodefi-
ciency and dialysis patients are prone to infectious
complications. We describe a haemodialysis patient
who acquired a wound infection and bacteraemia with
Streptococcus uberis, which is a microorganism that causes
mastitis in cows but is considered non-pathogenic in
humans. We propose that invasive infection was facilitated
by a co-infection with Staphylococcus aureus. In addition,
we provide an overview of case reports of S. uberis infec-
tions in humans.
Case presentation
A 75-year-old male Caucasian haemodialysis patient pre-
sented with painful swelling and redness of his right fore-
foot. He had a fever of 39.0 °C and hypotension. C-reactive
protein was elevated at 300 mg/l and interleukin-6 was
1120 pg/ml. His leukocyte count was 20 G/l. One week* Correspondence: Karl.lhotta@lkhf.at
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unless otherwise stated.earlier he had fallen and suffered subluxation of the second
and third metatarsophalangeal joints of the right foot. Two
days later a haemorrhagic plantar bulla developed. At
presentation a secreting ulcer was visible at the region
of the second and third metatarsophalangeal joints. In a
swab specimen taken from wound secretion methicillin-
susceptible S. aureus, Acinetobacter baumannii, Proteus
vulgaris, S. uberis and Clostridium perfringens were cul-
tured. A concomitant blood culture sample was positive
for S. aureus and S. uberis.
The first toe had been amputated 4 months earlier be-
cause of staphylococcal osteomyelitis. The previous year
he had had an abscess on the left forefoot with septicae-
mia caused by methicillin-resistant staphylococci, and
this had required surgical drainage.
Clinically significant peripheral arterial vascular disease
was excluded. The next day an urgent transmetatarsal
amputation of the right forefoot was performed. A deep
wound swab led to growth of S. aureus and S. uberis.
Histology showed a fistulating ulcer affecting the bones,
putrid thrombophlebitis and gangrene of the plantar soft
tissue. The patient was treated with intravenous ampicillinal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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lowing 3 weeks. His clinical condition and inflamma-
tory parameters rapidly improved. Wound healing was
protracted and a secondary infection with S. aureus was
treated with linezolid. Six weeks after the incident the
patient had completely recovered.
The isolate of S. uberis was initially identified using
matrix-assisted laser desorption ionisation time-of-flight
mass spectrometry (MALDI TOF) (MALDI Biotyper©
Microflex LT, Bruker Daltonics, Bremen, Germany). The
S. uberis isolate obtained from the blood culture was sent
to the German National Reference Centre for Streptococci,
where the correct classification was confirmed by sequen-
cing the superoxide dismutase A gene.Discussion
To the best of our knowledge this is the first description
of S. uberis infection in a haemodialysis patient. S. uberis
is the most common pathogen causing mastitis in cows
worldwide [1]. S. uberis causes painful inflammation of
the udder and decreases the quantity and quality of milk
production. Because of antibiotic treatment of cows, S.
uberis isolates with decreased susceptibility to penicil-
lin, macrolides, aminoglycosides and clindamycin are
increasingly reported [2]. S. uberis infection of cattle
usually occurs after environmental exposure. One study
showed S. uberis in 63 % of environmental samples such
as water, soil, plant matter and hay [3]. In addition, 23 %
of 104 fecal samples were positive for S. uberis, with the
highest proportion observed during the summer grazing
season. Therefore, fecal shedding is probably the main
source of S. uberis infections in cattle.Table 1 Chronological list of case reports of S. uberis infection
Author, year Patients Type of infect
Sarkar, 1989 [7] 3 healthy adults pneumonia, b
Sanchez,1991 [12] healthy adult (rancher) hepatic absce
Murdoch, 1997 [8] 9-year-old child abscess after
laceration
Bouskraoui, 1998 [10] 11-month-old child with Down
syndrome, atriventricular canal
endocarditis
Lazinska, 2005 [6] renal transplant recipient urinary tract i
Huang, 2007 [19] 2-year-old child, acute myeloid
leukaemia
bacteraemia
Kessel, 2008 [9] healthy adult gonarthritis, m
abscess




Gülen, 2013 [5] healthy, age not specified urinary tract i
(7 out of 148
aManufacturers of diagnostic tests: API 20 STREP and VITEK are provided by BioMer
Company, USAS. uberis is considered non-pathogenic to humans. The
species difference in pathogenicity is at least partly ex-
plained by the fact that S. uberis plasminogen activator
(SUPA) activates bovine, but not human, plasminogen
[4]. Activation of the plasminogen system causes degrad-
ation of the extracellular matrix and facilitates spreading
of bacteria and invasive infection.
S. uberis belongs to the family of viridans streptococci.
This pathogen has rarely been identified in human clin-
ical microbiological samples. S. uberis has been reported
as a cause of urinary tract infection. Gülen et al. described
seven cases out of 148 culture-positive urinary tract infec-
tions from patients living in a rural Turkish region [5].
The authors speculate that patients became infected
through frequent contact with cows and milk. One other
case of S. uberis urinary tract infection was described by
Lazinska et al. in 47 urine samples from 42 renal trans-
plant recipients [6]. Unfortunately, clinical presentation,
treatment and outcome in patients with S. uberis urinary
tract infection have not been specified in detail. S. uberis
has also been found to be a cause of bacterial pneumonia.
Sarkar et al. described three cases of pneumonia with
positive blood cultures [7]. All three patients recovered
with iv penicillin therapy. Murdoch and MacFarlane de-
scribed S. uberis as the cause of abscess formation after
a scalp laceration from a horse kick in a child [8]. The
child recovered after drainage and antibiotic therapy with
amoxicillin and cotrimoxazole. Another case report de-
scribed gonarthritis and soft tissue abscess caused by S.
uberis [9]. The patient was treated with surgical drainage
and cefuroxime, clindamycin and penicillin. In addition,
endocarditis in a child with Down syndrome and an atrio-
ventricular canal has also been reported [10]. A case ofion Diagnostic testa Treatment Outcome
acteraemia API 20 STREP iv penicillin recovered
ss VITEK drainage, ampicillin recovered
scalp API 20 STREP drainage, amoxicillin,
cotrimoxazole
recovered
not specified amoxicillin, clavulanic
acid, gentamiycin
recovered
nfection API 20 STREP not specified not stated
not specified not specified not stated














not specified not stated
ieux, France, and BBL Crystal™ is provided by Becton Dickinson and
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fication and vitrectomy for proliferative diabetic nephrop-
athy has been described in a patient with diabetes and
end-stage renal disease on peritoneal dialysis [11]. Sanches
et al. reported a rancher, in whom S. uberis was identi-
fied from a hepatic abscess [12]. Table 1 shows previous
reports of S. uberis infection. In summary, including
our case we were able to identify 17 cases of S. uberis
infection. In eight of these cases direct or indirect con-
tact with cattle or milk and dairy products was suspected.
Our case is exceptional in several respects. First, to the
best of our knowledge this is the only case in which the
presence of S. uberis in a human clinical sample was con-
firmed by modern methodology, including MALDI TOF
and superoxide dismutase A gene sequencing. These tests
are currently the best methods for unequivocal classifica-
tion of S. uberis [13, 14]. S. uberis is notoriously difficult
to identify. In a study of 1227 S. viridans clinical human
samples seven were initially classified as S. uberis [15].
However, in retrospect, using newer technology all of
these samples were reclassified as Globicatella sanguinis
[16]. In addition, S. uberis and enterococci appear to be
difficult to distinguish by phenotypical testing only [17].
In the case reports listed in Table 1 diagnosis of S. uberis
was established by phenotypical testing. Some of these
infections might have been misclassified as previously
suspected [18].
Second, this is the only report of S. uberis and S aur-
eus co-infection requiring an amputation. Thirdly, to the
best of our knowledge concomitant S. uberis wound in-
fection and bacteraemia have also not been previously
reported. In addition, our patient had deep wound infec-
tion with osteomyelitis and bacteraemia caused by S. uberis
and S. aureus coinfection. He also had a mixed wound in-
fection including several other bacteria that were found in
superficial wound secretion. From a clinical point of view
the exact pathogenetic roles of S. uberis and S. aureus are
difficult to determine in our case. Because S. aureus is a
highly pathogenic and tissue-invasive bacteria, we specu-
late that it was the primary and leading pathogen and facil-
itated subsequent invasion by S. uberis. Whether S. uberis
alone would have been able to cause the severe infection is
unknown but we believe this is unlikely. Notably, none of
the other case reports mentioned co-infection with other
more aggressive bacteria. Fortunately, S. uberis and S. aur-
eus that were present in the deep wound and blood were
susceptible to all tested antibiotics and the patient quickly
recovered under ampicillin/sulbactam treatment. In case of
a difference in antibiotic susceptibility between them we
would have chosen an antibiotic combination therapy to
target both organisms.
Notably, our case of a haemodialysis patient with
wound infection and bacteraemia, a case of a peritoneal
dialysis patient with endophthalmitis and a case of a renaltransplant patient with urinary tract infection suggest that
patients on renal replacement therapy are particularly
susceptible to S. uberis infection [6, 11].
The last remaining question is how the patient acquired
this rare infection. He had suffered two additional serious
foot infections in the preceding year. The patient was a
staunch barefoot walker and had calloused feet with
multiple lacerated wounds on his soles. During the sum-
mer months he used to hike barefoot across mountain
pastures. Summer is also the cattle grazing season, when
alpine pastures are densely populated by cows. We believe
that the patient inadvertently stepped in one of the
innumerable cow pats that cover alpine pastures, thereby
translocating the cow's faecal shedding into the cutaneous
clefts. His fall with subluxation of the toe may have caused
some of this material to translocate into deeper tissues,
where it served as a nidus for the infection.
Conclusion
In summary, we report the first case of S. uberis osteomye-
litis and wound and bloodstream infection in a haemodi-
alysis patient. This is the only case of a human infection
that was diagnosed by modern microbiological method-
ology. Invasive infection was most likely facilitated by S.
aureus co-infection. We recommend that immunocom-
promised patients should not to walk barefoot over cattle
grazing pastures.
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